Protein differences in POAG subjects

Regulatory agencies issued approvals for new treatments and expanded uses of existing therapies in the retina space

Both trials failed to meet their primary endpoints for treatment of age-related macular degeneration

How studies into myopia management can increase access to vision care

A pivotal phase 3 clinical trial found that SYD-101 met its 3-year primary endpoint for slowing paediatric myopia progression

Hematologists and ophthalmologists could work together for earlier diagnoses, research findings indicate